273 related articles for article (PubMed ID: 18155955)
1. Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium(VI) with the drinking water.
De Flora S; D'Agostini F; Balansky R; Micale R; Baluce B; Izzotti A
Mutat Res; 2008; 659(1-2):60-7. PubMed ID: 18155955
[TBL] [Abstract][Full Text] [Related]
2. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses.
De Flora S; Iltcheva M; Balansky RM
Mutat Res; 2006 Nov; 610(1-2):38-47. PubMed ID: 16872865
[TBL] [Abstract][Full Text] [Related]
3. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
[TBL] [Abstract][Full Text] [Related]
4. Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water.
Sedman RM; Beaumont J; McDonald TA; Reynolds S; Krowech G; Howd R
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006 Apr; 24(1):155-82. PubMed ID: 16690539
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water.
Kopec AK; Kim S; Forgacs AL; Zacharewski TR; Proctor DM; Harris MA; Haws LC; Thompson CM
Toxicol Appl Pharmacol; 2012 Feb; 259(1):13-26. PubMed ID: 22155349
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights from the NTP studies of chromium.
Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
[TBL] [Abstract][Full Text] [Related]
8. Haloacetonitriles: metabolism and toxicity.
Lipscomb JC; El-Demerdash E; Ahmed AE
Rev Environ Contam Toxicol; 2009; 198():169-200. PubMed ID: 19253036
[TBL] [Abstract][Full Text] [Related]
9. Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice.
Davidson T; Kluz T; Burns F; Rossman T; Zhang Q; Uddin A; Nadas A; Costa M
Toxicol Appl Pharmacol; 2004 May; 196(3):431-7. PubMed ID: 15094314
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice.
Kirpnick-Sobol Z; Reliene R; Schiestl RH
Cancer Res; 2006 Apr; 66(7):3480-4. PubMed ID: 16585171
[TBL] [Abstract][Full Text] [Related]
11. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure.
Finley BL; Kerger BD; Katona MW; Gargas ML; Corbett GC; Paustenbach DJ
Toxicol Appl Pharmacol; 1997 Jan; 142(1):151-9. PubMed ID: 9007044
[TBL] [Abstract][Full Text] [Related]
12. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium.
Kirman CR; Hays SM; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM
Chem Biol Interact; 2012 Oct; 200(1):45-64. PubMed ID: 22981460
[TBL] [Abstract][Full Text] [Related]
13. Chromium in drinking water: sources, metabolism, and cancer risks.
Zhitkovich A
Chem Res Toxicol; 2011 Oct; 24(10):1617-29. PubMed ID: 21766833
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
15. Waterborne and dietary hexavalent chromium exposure causes DNA-protein crosslink (DPX) formation in erythrocytes of largemouth bass (Micropterus salmoides).
Kuykendall JR; Miller KL; Mellinger KN; Cain AV
Aquat Toxicol; 2006 Jun; 78(1):27-31. PubMed ID: 16672167
[TBL] [Abstract][Full Text] [Related]
16. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
[TBL] [Abstract][Full Text] [Related]
17. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis.
De Flora S
Carcinogenesis; 2000 Apr; 21(4):533-41. PubMed ID: 10753182
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of gene expression in rat lung by hexavalent chromium.
Izzotti A; Cartiglia C; Balansky R; D'Agostini F; Longobardi M; De Flora S
Mol Carcinog; 2002 Oct; 35(2):75-84. PubMed ID: 12325037
[TBL] [Abstract][Full Text] [Related]
19. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues.
Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S
Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
Williams GM; Iatropoulos MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
